A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines.

Crews, J R; Maier, L A; Yu, Y H; Hester, S; O'Briant, K; Leslie, D S; DeSombre, K; George, S L; Boyer, C M; Argon, Y

Crews, J R; Maier, L A; Yu, Y H; Hester, S; O'Briant, K; Leslie, D S; DeSombre, K; George, S L; Boyer, C M; Argon, Y.

Affiliation

Crews JR; Department of Medicine, Duke University Medical Center, Durham, NC 27710.

Int J Cancer ; 51(5): 772-9, 1992 Jul 09.

Article in En | MEDLINE | ID: mdl-1351885

Subject(s)

Breast Neoplasms/drug therapy; Immunotoxins/administration & dosage; Ricin/administration & dosage; Antibodies, Monoclonal/metabolism; Antigens, Neoplasm/immunology; Antigens, Surface/immunology; Breast Neoplasms/immunology; Drug Synergism; Endocytosis; Gold; Humans; Immunotoxins/therapeutic use; Kinetics; Microscopy, Electron; Oncogene Proteins, Viral/immunology; Receptor, ErbB-2; Receptors, Transferrin/immunology; Recombinant Proteins/administration & dosage; Recombinant Proteins/therapeutic use; Ricin/therapeutic use; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ricin / Breast Neoplasms / Immunotoxins Limits: Humans Language: En Journal: Int J Cancer Year: 1992 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links